Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+7.72%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$39.7B
AUM Growth
+$39.7B
(+8.4%)
Cap. Flow
+$1.21B
Cap. Flow
% of AUM
3.06%
Top 10 Holdings %
Top 10 Hldgs %
13.97%
Holding
792
New
111
Increased
261
Reduced
278
Closed
96
Top Buys
| 1 |
Deere & Co
DE
|
$213M |
| 2 |
Abbott
ABT
|
$147M |
| 3 |
Illinois Tool Works
ITW
|
$139M |
| 4 |
Morgan Stanley
MS
|
$133M |
| 5 |
Meta Platforms (Facebook)
META
|
$117M |
Top Sells
| 1 |
STJ
St Jude Medical
STJ
|
$276M |
| 2 |
Wells Fargo
WFC
|
$221M |
| 3 |
Johnson Controls International
JCI
|
$185M |
| 4 |
Humana
HUM
|
$146M |
| 5 |
B
Barrick Mining Corporation
B
|
$142M |
Sector Composition
| 1 | Healthcare | 14.15% |
| 2 | Technology | 13.51% |
| 3 | Financials | 12.89% |
| 4 | Industrials | 10.96% |
| 5 | Consumer Discretionary | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
V2X
VVX
$1.79B
| $2.76M | 0.01% |
123,637
+100,100
| +425% | +$2.24M |
|
652
Campbell Soup
CPB
$9.36B
| $2.76M | 0.01% |
+48,254
| New | +$2.76M |
|
|
ADAP
653
Adaptimmune Therapeutics
ADAP
$15.4M
| $2.67M | 0.01% |
483,901
-50,000
| -9% | -$275K |
|
654
Tempest Therapeutics
TPST
$44.6M
| $2.39M | 0.01% |
1,280,000
| – | – |
|
655
Aldeyra Therapeutics
ALDX
$347M
| $2.38M | 0.01% |
+475,000
| New | +$2.38M |
|
656
Vince Holding
VNCE
$19M
| $2.33M | 0.01% |
1,500,000
| – | – |
|
657
News Corp Class B
NWS
$18.8B
| $2.3M | 0.01% |
170,065
-2,500
| -1% | -$33.8K |
|
658
Hamilton Lane
HLNE
$6.56B
| $2.15M | 0.01% |
+115,000
| New | +$2.15M |
|
659
Steris
STE
$23.9B
| $2.13M | 0.01% |
+30,625
| New | +$2.13M |
|
|
GNMX
660
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $2.05M | 0.01% |
1,100,000
-1,000,000
| -48% | -$1.86M |
|
|
STDY
661
DELISTED
SteadyMed Ltd
STDY
| $2.03M | 0.01% |
350,000
+100,000
| +40% | +$580K |
|
662
AdvanSix
ASIX
$565M
| $1.98M | 0.01% |
72,516
-19,960
| -22% | -$545K |
|
663
Annaly Capital Management
NLY
$13.4B
| $1.67M | ﹤0.01% |
+150,000
| New | +$1.67M |
|
|
AAV
664
DELISTED
Advantage Oil & Gas Ltd
AAV
| $1.65M | ﹤0.01% |
+250,000
| New | +$1.65M |
|
665
Bank of N.T. Butterfield & Son
NTB
$1.85B
| $1.6M | ﹤0.01% |
50,000
| – | – |
|
|
WMGI
666
DELISTED
Wright Medical Group Inc
WMGI
| $1.56M | ﹤0.01% |
+50,000
| New | +$1.56M |
|
|
GPOR
667
DELISTED
Gulfport Energy Corp.
GPOR
| $1.46M | ﹤0.01% |
85,000
| – | – |
|
|
BDSI
668
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.43M | ﹤0.01% |
750,000
+250,000
| +50% | +$475K |
|
669
Permian Resources
PR
$10.1B
| $1.36M | ﹤0.01% |
74,792
-915,000
| -92% | -$16.7M |
|
|
GM.WS.B
670
DELISTED
General Motors Company
GM.WS.B
| $1.34M | ﹤0.01% |
75,000
| – | – |
|
671
Halozyme
HALO
$8.64B
| $1.3M | ﹤0.01% |
+100,000
| New | +$1.3M |
|
672
Clearside Biomedical
CLSD
$26.1M
| $1.25M | ﹤0.01% |
+157,000
| New | +$1.25M |
|
|
DS
673
DELISTED
Drive Shack Inc.
DS
| $1.25M | ﹤0.01% |
300,000
| – | – |
|
674
BlueLinx
BXC
$648M
| $1.24M | ﹤0.01% |
136,300
| – | – |
|
675
Brookline Bancorp
BRKL
$976M
| $1.17M | ﹤0.01% |
75,000
| – | – |
|